Clinical Presentation and Outcomes of Phaeochromocytomas/Paragangliomas in Neurofibromatosis Type 1

Introduction: Patients with neurofibromatosis type 1 (NF1) are at risk of developing phaeochromocytomas/paragangliomas (PHAEO/PG). Unlike in other familial PHAEO/PG syndromes, there are no published guidelines regarding screening in asymptomatic or normotensive patients with NF1. This strategy may b...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Sharefi, Ahmed, Javaid, Usman, Perros, Petros, Ealing, John, Truran, Peter, Nag, Sath, Kamaruddin, Shafie, Abouglila, Kamal, Cains, Fiona, Lewis, Lauren, James, Robert Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Touch Medical Media 2019
Materias:
Neuroendocrine Tumours
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785954/
https://www.ncbi.nlm.nih.gov/pubmed/31616500
http://dx.doi.org/10.17925/EE.2019.15.2.95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785954/
https://www.ncbi.nlm.nih.gov/pubmed/31616500
http://dx.doi.org/10.17925/EE.2019.15.2.95

Ejemplares similares